News Focus
News Focus
icon url

chickpea598

05/21/19 9:42 AM

#46806 RE: trading.jeff #46805

What is encouraging is that Oncosec results in IL-12 TAVO therapy with Keytruda has gained credible interest. Things are moving forward. TNBC combo data will be an eye-opener...Merck needs something to work in TNBC.